Features

Features

• Analyzing therapeutic psychedelics: Opportunities, challenges

  Experts at the 2024 WMIF discuss the challenges and opportunities associated with therapeutic psychedelics, including cost, access, continued innovation and patient management.  Continue Reading

• Advancing continuous manufacturing with FDA support

  Continuous manufacturing is transforming pharmaceuticals with FDA support, bringing faster production, cost savings and improved quality to the industry.  Continue Reading

• 2025 life sciences industry outlook: What's next?

  A 2025 life sciences industry outlook report identifies several focus areas, including digital transformation, competitive pressures, business volatility and evolving customer needs.  Continue Reading

• Understanding the impact of food safety recalls, regulation

  Food safety regulations are key to protecting public health, ensuring safe consumption and maintaining consumer trust amid complex global food systems.  Continue Reading

• Anticipating the healthcare reach of GLP-1 receptor agonists

  Thought leaders at the 2024 WMIF discussed how cost, drug shortages, compounding pharmacies and insurance coverage for GLP-1 receptor agonists will impact the future landscape.  Continue Reading

• Exploring the secondary prevention of cervical cancer

  Molecular tests, sampling, cytologic techniques, visual assessment and precancer treatment play a critical tool in the secondary prevention of cervical cancer.  Continue Reading

• Revolutionizing women's health technology through innovation

  As more scientists and innovators work toward addressing the gaps in women's healthcare, women's health technology and the ongoing innovation in tech will be critical tools.  Continue Reading

• Adopting plant-based plastics to create single-use systems

  The biopharmaceutical industry is adopting plant-based, single-use plastic systems to reduce its environmental impact and meet industry standards for safety and compliance.  Continue Reading

• Employing ML to boost pharmacokinetics in drug development

  Machine learning revolutionizes pharmacokinetics by accurately predicting drug behavior and optimizing dosages, streamlining drug development and regulatory approval.  Continue Reading

• Exploring biomarker strategies in rare disease therapeutics

  Innovative biomarker strategies and regulatory flexibility from the FDA are helping to streamline rare disease therapy development, addressing patient needs more effectively.  Continue Reading

• AMPEL develops a blood test for cardiovascular disease

  Amrie Grammer, AMPEL's co-founder, president, and chief scientific officer of AMPEL BioSolutions, explains the company's CardioGENE blood test for cardiovascular disease risk.  Continue Reading

• Role of advanced modeling and virtual data in drug approvals

  Advanced modeling and virtual data help biopharma companies design efficient, ethical and cost-effective trials to accelerate drug development and regulatory approvals.  Continue Reading

• Addressing gene and cell therapy commercialization challenges

  InspiroGene addresses some gene and cell therapy commercialization challenges by offering logistics programs, distribution services, a biologics specialty pharmacy and a patient hub.  Continue Reading

• Advancing sustainability in biopharmaceutical manufacturing

  Sustainable biopharmaceutical manufacturing is adopting green technologies to minimize waste, optimize processes and uphold product quality amid regulatory and environmental challenges.  Continue Reading

• Understanding PMBs' role and impact on drug pricing

  PBMs shape drug pricing and healthcare costs, but growing market consolidation sparks concerns about less competition, higher prices and fewer options for patients.  Continue Reading

• Exploring emerging breast cancer screening tools, technology

  New breast cancer screening tools, ranging from 3D mammography to AI-assisted screening analysis play a critical role in the evolving breast cancer screening landscape.  Continue Reading

• Climate change drives drug demand for chronic conditions

  As climate change intensifies, the pharmaceutical industry faces a new challenge: rising drug demand for climate-sensitive chronic conditions amid more frequent extreme weather events.  Continue Reading

• What would a CVS Health breakup mean for stakeholders?

  Antonio Ciaccia discusses what a CVS Health breakup could look like and what that would mean for the pharmaceutical marketplace and various stakeholders.  Continue Reading

• Are compounded GLP-1 drugs safe?

  Growing demand for GLP-1 weight loss drugs has caused market shortages, prompting compounding pharmacies to offer alternatives that raise safety and reliability issues.  Continue Reading

• Exploring injectable allergy medicines as the season extends

  Epinephrine, corticosteroids, monoclonal antibodies and allergy immunotherapies are injectable allergy medicines that can offer severe allergy relief as seasons are prolonged.  Continue Reading

• Addressing CGT reimbursement challenges

  The PharmaLifeSciences 2024 summit highlighted the reimbursement barriers to cell and gene therapies and discussed policy reforms to ensure patient access and sustainability.  Continue Reading

• Advancing medicine through cell and gene therapy

  Cell and gene therapy is transforming medicine by offering potential cures for untreatable diseases, but navigating scientific and regulatory hurdles remains challenging.  Continue Reading

• Understanding regulatory pathways for medical devices

  Medical device regulation ranges from discovery to post-market regulation; however, the regulatory pathways for medical devices depend on classification.  Continue Reading

• Using synthetic biomarkers for early cancer detection

  Using a synthetic targeting platform that forces cancer cells to express synthetic biomarkers, Earli Inc. is developing strategies for early cancer detection.  Continue Reading

• Enhancing patient care with clinical decision-making AI

  Clair by CaryHealth uses AI to enhance clinical decision-making, providing healthcare professionals with fast, evidence-based insights and seamless integration.  Continue Reading

• How will the NOPAIN Act impact Medicare beneficiaries?

  The NOPAIN Act might alter Medicare prescribing by mandating coverage and expanding access to non-opioid treatments, promoting research, and facilitating education.  Continue Reading

• Understanding significant mosquito-borne diseases

  Common mosquito-borne illnesses, such as Zika virus, West Nile virus, Chikungunya virus, dengue, and malaria, pose public health threats for various communities.  Continue Reading

• Formulating a specialty drug management playbook using expert insights

  Using this playbook, healthcare organizations can better navigate the complexities of specialty drug management to optimize care, control costs, and improve patient outcomes.  Continue Reading

• Exploring trends shaping the future of specialty pharmacy

  The pharmacy industry is evolving with specialty drugs, requiring advanced management and technology solutions to control costs and improve patient outcomes.  Continue Reading

• Recognizing the growing impact of climate change on infectious diseases

  As climate change worsens, its growing impact on global health is becoming alarmingly evident, particularly through the spread of infectious diseases.  Continue Reading

• Exploring AI applications in radiology

  Artificial intelligence can play many roles in radiology, including image analysis, interpretation, disease detection, and more.  Continue Reading

• Exploring FDA-approved birth control injections

  Injectable contraceptives, like Depo-Provera and Depo-SubQ Provera 104, are name-brand FDA-approved hormonal birth control methods that prevent pregnancy.  Continue Reading

• Exploring FDA-approved vaginal rings for birth control

  Vaginal rings, like NuvaRing, Annovera, and EluRyng, are FDA-approved hormonal birth control methods that effectively prevent pregnancy.  Continue Reading

• Understanding the role of 4D printing in the healthcare industry

  Adding to the evolution of 3D printing, 4D printing provides an additional tool for enhancing healthcare outcomes.  Continue Reading

• Exploring FDA-approved cell, gene therapeutic products

  Despite wildly high costs, FDA-approved cell and gene therapeutic products are revolutionizing healthcare with innovative treatments for once-incurable diseases.  Continue Reading

• Understanding artificial womb technology for preterm infants

  Artificial womb technology may present an opportunity for better outcomes among preterm infants; however, it also comes with many challenges.  Continue Reading

• Understanding the endocannabinoid system's role in maintaining physiological balance

  The endocannabinoid system, a complex cell-signaling network, is vital in maintaining physiological balance by regulating key processes such as mood, pain, and immune response.  Continue Reading

• 2023 USP Report highlights economic factors driving drug shortages

  The USP's 2023 report links drug shortages to economic factors, urging policy reforms, pricing adjustments, and supply chain diversification.  Continue Reading

• Analyzing USPSTF's updated breast cancer screening recommendations

  The new USPSTF breast cancer guidelines recommend biannual screenings starting at age 40, raising concerns about missed cases, dense breast tissue, and equitable access.  Continue Reading

• Understanding the differences between 503A, 503B compounding pharmacies

  Compounding pharmacies customize medications for patients, with 503A serving individual prescriptions and 503B producing larger batches for healthcare facilities.  Continue Reading

• Combating the prescription drug shortage crisis

  Prescription drug shortages have reached record highs in the United States, prompting companies to develop integrated technological solutions to address ongoing challenges.  Continue Reading

• Managing bird flu risks with advances in prevention

  Bird flu, caused by viruses like H5N1 and H7N9, poses severe risks to humans, especially those in close contact with birds, but preventative measures can curb transmission.  Continue Reading

• Exploring 5 types of clinical trial data sharing platforms

  Trial registries, result repositories, open data platforms, sponsor-specific platforms, and consortium-based platforms are five types of clinical trial data-sharing platforms.  Continue Reading

• Emerging solutions to address the environmental impact of pregnancy tests

  The global plastic waste crisis, driven by excess single-use plastics like pregnancy tests, is a major concern; however, innovative options offer eco-friendly solutions.  Continue Reading

• Exploring FDA-approved GLP-1 receptor agonists

  Glucagon-like peptide-1 (GLP-1) receptor agonists regulate blood sugar and aid weight loss, offering diverse applications beyond diabetes treatment.  Continue Reading

• Geroscience: targeting aging mechanisms for preventing chronic disease

  Geroscience is an emerging field focusing on understanding and addressing aging mechanisms to avoid age-related chronic diseases.  Continue Reading

• CDRH reports highlight progress in medical device safety, innovation

  The Center for Devices and Radiological Health’s recent reports highlight significant advancements in medical device safety, innovation, and regulatory oversight.  Continue Reading

• Exploring the top 20 biopharma companies Q1 2024 market cap growths

  Of the top 20 biopharmaceutical companies to see a profitable Q1 in 2024, Lilly leads with a 33.7% increase, with Nordisk in second, outperforming Johnson & Johnson.  Continue Reading

• Improving mammography utilization to cut breast cancer mortality

  According to a CDC report, mammography utilization decreases with adverse social determinants of health.  Continue Reading

• Discovering 6 applications of bioinformatics in drug repurposing

  Bioinformatics plays a critical role across pharmaceutical innovation, with many applications in drug discovery and repurposing.  Continue Reading

• Exploring 10 ethical considerations in genome editing

  While gene editing may be critical for improving human health, ethical considerations must be made to mitigate risks.  Continue Reading

• Evaluating the safety profile of mifepristone

  Evaluating the safety profile of mifepristone amid legal debates and access challenges underscores its importance in reproductive healthcare.  Continue Reading

• Heart devices linked to injuries, deaths receive FDA's most serious recall

  The FDA has issued the highest recall classification for Abbott’s HeartMate II and HeartMate 3 devices linked to 100s of injuries and 14 deaths.  Continue Reading

• Exploring 3 common types of viral hepatitis: hepatitis A, B, C

  Hepatitis A, B, and C are the most common types of viral hepatitis; however, vaccines and treatments can help mitigate disease spread.  Continue Reading

• Exploring 5 types of intellectual property protections in pharma

  Patents, trademarks, copyrights, trade secrets, and regulatory exclusivities offer intellectual property protections to pharmaceutical companies.  Continue Reading

• Exploring digital stethoscope technology for improved diagnostics

  Digital stethoscopes enhance diagnostics by precisely amplifying and analyzing cardiopulmonary sounds, leading to earlier detection and improved patient outcomes.  Continue Reading

• Understanding the environmental impact of the pharmaceutical industry

  Though vital for global health, the pharmaceutical industry's significant environmental impact warrants attention.  Continue Reading

• Exploring RNA-based therapeutics beyond mRNA vaccines

  RNA therapeutics beyond mRNA vaccines can have revolutionary impacts on the healthcare industry, providing new tools to care for patients.  Continue Reading

• Strategies for engaging, managing KOLs in the pharma industry

  Pharmaceutical companies must accurately identify KOLs and develop specific engagement and management strategies to gather the valuable insights they can offer.  Continue Reading

• Assessing the impacts of noncontinuous digital diabetes solutions

  Peterson Health Tech Institute's report assesses noncontinuous digital diabetes management solutions and their clinical and economic impacts.  Continue Reading

• Applying pharmacometabolomic data for personalized medicine

  Pharmacometabolomics can provide additional context for personalized medicine by offering insights beyond genetic data.  Continue Reading

• Tailoring medication selection with pharmacogenomic testing

  Pharmacogenomic testing identifies genetic factors affecting drug response and reduces the risk of adverse reactions.  Continue Reading

• Understanding litigation against drug, medical device manufacturers

  Understanding the surge in litigation against drug and medical device manufacturers is crucial for navigating legal complexities and ensuring patient safety.  Continue Reading

• FDA-approved insulin pumps used for insulin pump therapy

  FDA-approved insulin pumps offer precise insulin pump therapy, revolutionizing diabetes management with personalized care.  Continue Reading

• Understanding HIV drug resistance, implications for treatment strategies

  Understanding HIV drug resistance aids in developing effective treatments, optimizing patient care, and combating therapeutic failure in HIV management.  Continue Reading

• How can gene therapies address inherited blindness?

  With over 220 genes contributing to inherited blindness, researchers continue assessing how gene therapies and editing can treat or cure the conditions.  Continue Reading

• Enhancing diabetes management with innovative insulin pump technology

  Innovative insulin pumps have revolutionized diabetes care by offering precise control, enhancing patient outcomes, and advancing healthcare technology.  Continue Reading

• Exploring Transparency-Rx’s pharmacy benefit manager partners

  This article explores "transparent" partners: SmithRx, Liviniti, AffirmedRx, RxPreferred, Navitus Health Solutions, Pharmacy Benefit Dimensions, Salvus, and MedOne.  Continue Reading

• Revolutionizing Vaccine Storage and Distribution with Innovative Solutions

  Vaccine storage and distribution innovations are crucial for ensuring vaccine efficacy, expanding accessibility, and enhancing real-time monitoring.  Continue Reading

• Using Next-Generation Antibiotics to Combat Antimicrobial Resistance

  Next-generation antibiotics combat antimicrobial resistance by targeting resistant pathogens to preserve effective healthcare treatments.  Continue Reading

• Continuous Manufacturing Revolutionizes Pharmaceutical Production

  Continuous manufacturing transforms pharmaceutical production, enhancing efficiency and supply chain resilience.  Continue Reading

• Exploring the Surge of Early-Onset Stomach Cancer

  The uptick in stomach cancer cases in individuals under 50 challenges conventional cancer trends, stressing the need for deeper research and understanding.  Continue Reading

• Exploring 5 Healthcare Imaging Techniques: Uses and Limitations

  Advanced imaging techniques play a critical role across healthcare, with a hand in diagnostics and disease monitoring.  Continue Reading

• Understanding Digital Health Passports in a Post-Pandemic World

  In the digital post-pandemic world, digital health passports may be a critical public health tool for minimizing disease spread and contact tracing.  Continue Reading

• How Do Social Isolation and Loneliness Impact Healthcare Outcomes?

  As the epidemic of social isolation and loneliness increases globally, especially in the US, understanding the healthcare impacts of these conditions is critical.  Continue Reading

• Advancing Packaging Technologies for Climate-Adaptive Supply Chains

  Advancing packaging tech for climate-adaptive pharma supply chains is crucial to protect product integrity, ensure patient safety, and minimize environmental impact.  Continue Reading

• Senate Report Exposes Big Pharma's Profiteering at Americans’ Expense

  US Senate HELP Committee's 2024 report exposes J&J, Merck, and BMS for prioritizing profits over Americans' well-being with exorbitant drug prices.  Continue Reading

• Maximizing Personalized Approaches with Precision Vaccinology

  Personalized vaccine development tailors immunization to individual needs, enhancing efficacy, safety, and disease prevention in a patient-centered approach.  Continue Reading

• Advancing Sterility Assurance Through Environmental Monitoring

  Environmental monitoring ensures pharmaceutical product safety by detecting and controlling contamination risks and maintaining quality standards.  Continue Reading

• Revolutionizing Diabetes Care with Advanced CGM Devices

  Advanced continuous glucose monitoring (CGM) devices offer real-time glucose readings, eliminating frequent finger stick testing to monitor blood sugar levels.  Continue Reading

• Comparing Female Fertility Drugs: Use Cases, Effectiveness, Risks

  Despite the uses and effectiveness of female fertility drugs, they come with multiple risks that must be considered before prescribing or administering them.  Continue Reading

• Exploring Challenges, Successes in Solid Tumor Cell and Gene Therapy

  Despite the ongoing difficulty of developing cell and gene therapies for solid tumors, some early developments have laid the foundation for future successes.  Continue Reading

• Revolutionizing Fertility Treatment with a MicroICSI Device

  As an alternative to traditional in vitro fertilization, a new microICSI device is poised to streamline fertility treatments and revolutionize patient care.  Continue Reading

• Harnessing the Power of Microbiome-Based Therapies

  Microbiome-based therapies restore healthy microbes and metabolic networks to promote health by manipulating microbial communities and restoring balance.  Continue Reading

• Understanding the Risks Associated with BiPAP, CPAP Recalls

  With many patients globally using BiPAP and CPAP machines to manage sleep apnea, it is critical to understand how the recalls impact the patients using them.  Continue Reading

• A Pulse Check on Advancements in the Life Sciences, Pharma Industry

  A pulse check on the life sciences and pharmaceutical industry advancements highlights breakthroughs in gene therapy, targeted oncology, and male contraception.  Continue Reading

• Exploring Facets of the Cell and Gene Therapy Market

  LifeSciencesIntelligence explores the cell and gene therapy market, noting how it evolved in the past year.  Continue Reading

• Evaluating the Series of Infant Formula Recalls in the US

  PharmaNewsIntelligence explores the various stages of infant formula recalls in the US and how the FDA has adapted to minimize contamination.  Continue Reading

• 10 Ways CRISPR Advancements Are Reshaping Healthcare

  Recent CRISPR technology advancements are crucial in healthcare as they enable precise gene editing and offer new treatments for genetic diseases.  Continue Reading

• Ethical Guidelines, Emerging Regulations in Octopus Research

  Understanding octopus research guidelines is essential for ethical healthcare progress, ensuring breakthroughs align with moral standards and prioritize animal welfare.  Continue Reading

• Understanding the Pharmacotherapy of Hypertensive Disorders

  Understanding how to manage hypertensive disorders can help providers address the growing number of patients with hypertension and hypertension-related complications.  Continue Reading

• Navigating the Complex Terrain of Influenza Vaccine Strain Selection

  Effective influenza strain selection and vaccine production ensure seasonal vaccines align with virus evolution, enhancing prevention and global health outcomes.  Continue Reading

• Exploring 6 Common Types of Hypertensive Disorders, Disease Management

  Hypertensive disorders, including essential, secondary, gestational, white coat, and malignant hypertension and preeclampsia, significantly impact human health outcomes.  Continue Reading

• Understanding Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

  SNRIs play a critical role in managing psychiatric and pain disorders, with comparable effects to SSRIs.  Continue Reading

• Combating Specialty Drug Challenges in the Pharmaceutical Industry

  Rising specialty drug use demands cost and experience considerations for optimal patient outcomes.  Continue Reading

• Navigating Prostate Cancer: Insights, Advances, and Personalized Care

  Understanding prostate cancer is crucial to improving early detection and treatment outcomes.  Continue Reading

• Price Transparency Healthcare Policies Reduce Out-Of-Pocket Costs

  Healthcare policies should focus on increased price transparency in the payment systems to reduce out-of-pocket drug costs for patients.  Continue Reading

• Exploring Prescription Discount Cards’ Role in Medication Adherence

  Prescription discount cards offer savings to patients without adequate insurance coverage, improving medication adherence.  Continue Reading

• Leveraging Predictive Analytics for Effective Disease Management

  Predictive analytics transforms disease management by enabling early detection, personalized treatment, and optimized resource allocation in healthcare.  Continue Reading

• Embracing AI in Life Sciences: Opportunities for Healthcare Technology

  Embracing AI in life sciences is crucial for unlocking opportunities and advancing healthcare technology.  Continue Reading